- Home
- AVTE vs ZENV Comparison
AVTE vs ZENV Comparison
Compare AVTE & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTE
- ZENV
- Stock Information
- Founded
- AVTE 2018
- ZENV 2005
- Country
- AVTE United States
- ZENV Brazil
- Employees
- AVTE N/A
- ZENV N/A
- Industry
- AVTE Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- AVTE Health Care
- ZENV Technology
- Exchange
- AVTE Nasdaq
- ZENV Nasdaq
- Market Cap
- AVTE 72.5M
- ZENV 80.2M
- IPO Year
- AVTE 2021
- ZENV 2021
- Fundamental
- Price
- AVTE $2.75
- ZENV $1.28
- Analyst Decision
- AVTE Hold
- ZENV
- Analyst Count
- AVTE 7
- ZENV 0
- Target Price
- AVTE $11.75
- ZENV N/A
- AVG Volume (30 Days)
- AVTE 192.3K
- ZENV 60.4K
- Earning Date
- AVTE 05-12-2025
- ZENV 04-29-2025
- Dividend Yield
- AVTE N/A
- ZENV N/A
- EPS Growth
- AVTE N/A
- ZENV N/A
- EPS
- AVTE N/A
- ZENV N/A
- Revenue
- AVTE N/A
- ZENV $173,594,726.00
- Revenue This Year
- AVTE N/A
- ZENV $28.66
- Revenue Next Year
- AVTE N/A
- ZENV $2.98
- P/E Ratio
- AVTE N/A
- ZENV N/A
- Revenue Growth
- AVTE N/A
- ZENV 23.49
- 52 Week Low
- AVTE $1.25
- ZENV $1.02
- 52 Week High
- AVTE $25.29
- ZENV $3.88
- Technical
- Relative Strength Index (RSI)
- AVTE 72.33
- ZENV 36.66
- Support Level
- AVTE $2.61
- ZENV $1.20
- Resistance Level
- AVTE $2.82
- ZENV $1.51
- Average True Range (ATR)
- AVTE 0.11
- ZENV 0.19
- MACD
- AVTE 0.02
- ZENV -0.02
- Stochastic Oscillator
- AVTE 81.08
- ZENV 7.92
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.